Case Report: Stem Cell Therapy in Autism Spectrum Disorder

Stem Cell-Based Therapy in a 13-Year-Old Girl With Autism

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by differences in social communication, behavior, sensory processing, adaptability, and cognitive functioning. Adolescence can be a particularly challenging period for children with autism because of the substantial biological, emotional, behavioral, and social changes associated with puberty.

This case describes the clinical observation of a 13-year-old girl with autism spectrum disorder who presented with pronounced difficulties in social interaction, attention and learning engagement, behavioral flexibility, and adaptation to changes in her environment.

The patient underwent a five-day stem cell-based regenerative therapy protocol combining neural progenitor cells, neurotrophic factors, exosomes, and hematopoietic cells derived from umbilical cord blood. The treatment was administered using both intravenous and intranasal routes.

The observations described below represent an individual clinical case and should not be interpreted as evidence that stem cell therapy cures autism or that the observed changes can be attributed exclusively to the cellular treatment.

---

Patient Profile

The patient was a 13-year-old girl with a previously established diagnosis of autism spectrum disorder.

Before treatment, the clinical picture was characterized by significant difficulties in several functional domains:

• limited spontaneous social interaction;
• reduced willingness to engage with other people;
• difficulty maintaining attention during educational activities;
• low motivation for intellectual or learning tasks;
• behavioral rigidity and difficulty adapting to changes;
• pronounced fear or distress associated with changes in routine or unfamiliar situations;
• challenges associated with the transition through puberty.

The combination of autism-related behavioral characteristics and the developmental changes of adolescence made this a particularly complex clinical case.

---

Treatment Protocol of Stem Cell Therapy for Autism

The patient received a 5-day regenerative cell therapy protocol consisting of a combination of cellular and cell-derived biological components. Results of delay development treatment using stem cells therapy

The protocol included:

1. Neural progenitor cells representing the principal neural cell lines used in the protocol.
2. Neurotrophic factors / neurotrophins, intended within the protocol to support neurobiological signaling and neuronal function.
3. Exosomes, used as a cell-derived biological component.
4. Hematopoietic cells derived from umbilical cord blood.

1. Intravenous administration of the therapeutic components.
2. Intranasal administration through a nasal spray as part of the treatment protocol.

The multimodal approach was designed to provide both systemic and potentially central nervous system-directed exposure.

From a research perspective, the biological rationale for cell-based approaches in ASD remains under investigation. Proposed mechanisms discussed in the scientific literature include modulation of neuroinflammatory signaling, trophic support, neuroplasticity, and interactions with the neuroimmune system. However, these mechanisms should be regarded as hypotheses under investigation rather than established explanations for an individual patient's clinical response.

---

Clinical Observations After Stem Cell Treatment for Autism

Following completion of the five-day treatment protocol, substantial behavioral changes were observed by the patient's caregivers and clinical team.

One of the most notable changes was an increase in social engagement and spontaneous interpersonal contact.

Before treatment, the patient demonstrated significant difficulty initiating and maintaining social interactions. Following treatment, she became noticeably more socially engaged and actively sought interpersonal contact.

An especially notable observation was her increased willingness to interact physically and emotionally with people around her. According to the clinical observation, she began spontaneously hugging even people who were not previously familiar to her.

Another important change involved cognitive and learning engagement.

Before treatment, maintaining attention during educational activities was difficult and the patient showed limited spontaneous interest in intellectual tasks. Following the intervention, she began independently demonstrating an interest in mental activities and learning. Great results of autism stem cells treatment

These observations may indicate changes in several functional domains, including:

• social communication;
• spontaneous social initiation;
• emotional engagement;
• adaptability;
• attention;
• motivation for learning;
• participation in intellectual activities.

---

Before and After Stem Cell Therapy for Autism Spectrum Disorder

Clinical Domain	Before Therapy	After Therapy
Social interaction	Limited spontaneous interaction	Increased spontaneous social engagement
Contact with others	Difficulty initiating interpersonal contact	More frequent and spontaneous contact
Physical/social affection	Limited tendency to initiate physical affection	Spontaneously hugged other people, including unfamiliar individuals
Learning engagement	Difficulty maintaining engagement with educational activities	Increased interest in intellectual and learning activities
Attention to mental tasks	Low persistence and engagement	Greater willingness to participate in cognitive activities
Behavioral flexibility	Significant difficulty adapting to changes	Improved apparent adaptability according to observation
Response to unfamiliar situations	Fear/distress associated with changes	More open and socially responsive behavior was observed
Motivation	Limited spontaneous motivation for learning	Increased self-initiated interest in mental activities
Overall social behavior	More withdrawn and socially difficult	More open, interactive, and socially engaged

---

Clinical Significance of the Observation

The most clinically striking aspect of this case was not a single behavioral change but the simultaneous improvement observed across several functional domains.

The patient after stem cell therapy for autism spectrum disorder, demonstrated greater spontaneous social interaction, increased openness toward other people, enhanced interest in cognitive activities, and greater willingness to engage with her environment.

Research has proposed several possible mechanisms through which cellular therapies could influence the biological environment associated with ASD, including modulation of inflammatory pathways, secretion of neurotrophic factors, effects on neuroplasticity, and interaction with immune signaling. Recent reviews describe early clinical research involving cell-based approaches but also emphasize important limitations, including small sample sizes, heterogeneous protocols, open-label study designs, and insufficient long-term evidence.

This case is particularly notable because the patient was 13 years old and undergoing puberty, a period associated with substantial developmental and behavioral changes. Consequently, interpretation of treatment-related changes requires particular caution.

The observed increase in social engagement and learning motivation may be clinically meaningful, but controlled prospective studies would be required to determine whether similar changes occur consistently in other patients receiving comparable interventions.

Functional Outcomes Before and After Stem Cell-Based Therapy

Functional Domain	Before Therapy	After Therapy	Observed Outcome
Socialization	Limited spontaneous social interaction; reduced interest in communicating with others	Increased spontaneous interaction and active interest in other people	Marked improvement in social engagement
Interpersonal Contact	Rarely initiated contact with other people	Spontaneously approached and interacted with people, including unfamiliar individuals	Increased social initiation
Emotional Expression	Limited spontaneous expression of affection	Demonstrated spontaneous affection and began hugging other people	Increased emotional and social responsiveness
Cognitive Engagement	Low motivation for intellectual and educational activities	Independently demonstrated interest in cognitive and learning activities	Improved cognitive engagement
Attention and Learning	Difficulty maintaining attention and participating in structured learning	Greater willingness to participate in and sustain cognitive activities	Improved learning participation
Initiative	Activities frequently required external prompting	Increased spontaneous initiation of social and cognitive activities	Increased spontaneous initiative
Functional Independence	Greater dependence on adult prompting and assistance	Increased willingness to perform activities independently	Improved functional independence
Physical/Activity Participation	Limited spontaneous participation in activities	Greater spontaneous participation in physical and daily activities	Increased activity participation
Adaptability	Significant difficulty with changes and unfamiliar situations	Greater openness to new activities and environmental interaction	Improved behavioral adaptability
Overall Functioning	Predominantly limited social, cognitive, and independent engagement	More socially engaged, cognitively active, emotionally expressive, and independently motivated	Broad functional improvement observed

This case describes a 13-year-old girl with autism spectrum disorder who underwent a multimodal cell-based therapy protocol involving neural progenitor cells, neurotrophic factors, exosomes, and umbilical cord-derived hematopoietic cells administered through intravenous and intranasal routes.

Following treatment, marked changes were observed in social interaction, spontaneous interpersonal engagement, emotional openness, and motivation for intellectual activities.

The patient's increased social responsiveness—including spontaneous interaction with other people—and her newly observed interest in cognitive activities represent notable clinical observations.